CLINICAL_TRIALS
trial_result
· 2026-03-10
Clinical Trial Update: Study of BHV-1400 in IgA Nephropathy [Phase 1]
Summary
This document announces an ongoing Phase 1 clinical trial evaluating BHV-1400 for IgA nephropathy, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Biohaven Therapeutics Ltd. | Conditions: IgA Nephropathy | Phase 1 | Status: RECRUITING